← GrantMatch
HomeGrants

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular characterization of cancer

AgencyNational Institutes of Health
StatusPosted
Opportunity numberRFA-CA-27-002
Posted date06/03/2026
Application deadlineNov 10, 2026 12:00:00 AM EST
Award ceiling300,000
Award floornone
Estimated total funding5,900,000
Expected number of awards13
Who can applyRefer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Assistance Listing (CFDA)93.394
DescriptionThrough this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens used for basic, clinical, or epidemiological cancer research. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still require further development and rigorous technical validation to encourage adoption by the research community. Well-suited applications must propose the development of technologi
Agency contactNCI-IMAT@nih.gov
Official listinghttps://www.grants.gov/search-results-detail/360534

🔍 Search all grants →